CanSino jumps after update on inhalable COVID vaccine output capacity

Cansino Biologics

25/11/2022 03:15

** Hong Kong shares of CanSino Biologics Inc  6185.HK  jump
as much as 10.4% to HK$108.10, on course for the biggest daily
pct rise since Nov. 14, if gains hold
    ** Stock is the eighth most actively traded by turnover
    ** Co says production capacity for its Recombinant COVID-19
Vaccine for Inhalation, which has been included for emergency
use as a booster vaccine in China, is 1.5 million doses per day
and transportation capacity at 1 million doses each day
    ** Shanghai shares of CanSino Biologics  688185.SS  surge 7%
    ** Hang Seng Commerce & Industry Index  .HSNC  falls 2% and
healthcare index  .HSCIH  declines 1.8%
    ** Hang Seng Composite Index  .HSCI  and Hang Seng Index
 .HSI  both slip 1%
    ** As of last close, the Hong Kong-listed shares had fallen
45.6% this year, while Shanghai stock was down 29.8%
 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))